Breaking News
Get 40% Off 0
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March. Read full update
Close

Stella Pharma Corp (4888)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
301.00 -1.00    -0.33%
02:00:29 - Closed. Currency in JPY ( Disclaimer )
  • Volume: 42,100
  • Bid/Ask: 301.00 / 302.00
  • Day's Range: 299.00 - 305.00
Type:  Equity
Market:  Japan
ISIN:  JP3399680002 
Stella Pharma 301.00 -1.00 -0.33%

4888 Balance Sheet

 
Featured here, the Balance Sheet for Stella Pharma Corp, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
Advanced Balance Sheet
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Current Assets 3728 3629 3672 3792
Cash and Short Term Investments 2559 2572 2615 2710
Cash - - - -
Cash & Equivalents 2258 2572 2615 2710
Short Term Investments 301 - - -
Total Receivables, Net 50 101 67 59
Accounts Receivables - Trade, Net 50 101 67 59
Total Inventory 1040 908 932 940
Prepaid Expenses 58 41 52 39
Other Current Assets, Total 21 7 6 44
Total Assets 3926 4141 4196 4329
Property/Plant/Equipment, Total - Net 83 90 96 102
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net - - - -
Intangibles, Net 54 56 59 61
Long Term Investments 60 365 368 371
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 1 1 1 3
Other Assets, Total 1312 814 871 925
Total Current Liabilities 225 235 237 421
Accounts Payable - - 1 49
Payable/Accrued - - - -
Accrued Expenses 15 14 7 6
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 160 160 160 160
Other Current liabilities, Total 50 61 69 206
Total Liabilities 1256 1308 1350 1577
Total Long Term Debt 813 853 893 933
Long Term Debt 813 853 893 933
Capital Lease Obligations - - - -
Deferred Income Tax - - - -
Minority Interest - - - -
Other Liabilities, Total 218 220 220 223
Total Equity 2670 2833 2846 2752
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 2938 2938 3431 3300
Additional Paid-In Capital 195 195 351 220
Retained Earnings (Accumulated Deficit) -469 -305 -944 -778
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 6 5 8 10
Total Liabilities & Shareholders' Equity 3926 4141 4196 4329
Total Common Shares Outstanding 31.23 31.03 30.42 29.48
Total Preferred Shares Outstanding - - - -
* In Millions of JPY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

4888 Comments

Write your thoughts about Stella Pharma Corp
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email